2invest AG (ETR:2INV)
11.40
0.00 (0.00%)
Jan 6, 2026, 10:33 AM EST
2invest AG Market Cap
2invest AG has a market cap or net worth of €37.71 million as of November 20, 2026. Its market cap has decreased by 40.02% in one year.
Market Cap
37.71M
Enterprise Value
29.17M
Revenue
n/a
Global Rank
n/a
Country Rank
n/a
PE Ratio
n/a
ChartMarket Cap Chart
Since December 7, 2012, 2invest AG's market cap has increased from 35.90M to 37.71M, an increase of 5.02%. That is a compound annual growth rate of 0.35%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 37.71M | -40.02% |
| Dec 30, 2025 | 62.87M | -5.72% |
| Dec 30, 2024 | 66.68M | 65.71% |
| Dec 29, 2023 | 40.24M | -19.72% |
| Dec 30, 2022 | 50.12M | -32.92% |
| Dec 30, 2021 | 74.73M | -18.39% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Biotest GmbH & Co. KGaA | 1.20B |
| Novogenia AG | 76.20M |
| 2invest AG | 37.71M |
| Biomark Diagnostics | 25.34M |
| Vidac Pharma Holding | 10.69M |
| Chosa Oncology AB | 3.13M |
| Paion AG | 321.02K |
| bioXXmed AG | 254.19K |